Nanalyze
Nanalyze
✓

Gene Editing Updates - CRISPR, Intellia, and Beam

00:13:01
Podcasts
RSS
Link

ABOUT THIS EPISODE

Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Signup now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/rp9e1V8dfPk.

We revisit gene editing stocks once per year because things move very slowly in this space. While there may be upwards of 27 gene editing stocks out there, our focus is on the three biggest – Beam Therapeutics BEAM, Intellia Therapeutics NTLA, and CRISPR Therapeutics CRSP. Each of these companies is racing to bring treatments to market using their respective gene editing technologies. Of these three gene editing companies, CRISPR seems to be the furthest ahead as they await regulatory approval - in the USA and UK/Europe - for the first gene editing enabled therapy, exa-cel. These updates on gene editing stocks provide investors with the latest news on the biggest players.

Business
Investing
English
United States
Use API to fetch this episode in JSON

IN THIS EPISODE

Edit these tags

TRANSCRIPT 🔗

Are you the producer of this podcast? Add a podcast transcript
Need Audio-to-Text? Transcribe with Listen411 in Just 60 Seconds

SEARCH PAST EPISODES

Search past episodes of Nanalyze.
Embed this search bar to your website

OTHER EPISODES IN THIS PODCAST

The Nanalyze Verdict: Applovin Stock

The Nanalyze Verdict: Applovin Stock

$APP stock has become extremely popular lately after shares got a 50% haircut from their peak. This adtech darling has strong revenue growth, high margins, and a reasonable valuation. But, is Applovin stock a buy now? To answer that, we'll look at the bull and bear case for this black box AI stock.…
00:14:24
SHARE
SAVE
How to Build a Dividend Portfolio You Can Retire Comfortably On

How to Build a Dividend Portfolio You Can Retire Comfortably On

Warren Buffett famously said his life is a product of compound interest. That perfectly exemplifies the concept of the "Snowball Effect." As your portfolio grows, so do your dividends. When you reinvest those dividends, your portfolio grows faster, and your dividends grow faster. This lea…
00:09:44
SHARE
SAVE
How to Consistently Find Dividend Growth Stocks You Can Hold Forever

How to Consistently Find Dividend Growth Stocks You Can Hold Forever

Not all dividend stocks are the same. Some are traps that entice investors with the promise of a 10% yield. Others look boring but can deliver returns that are anything but. In this video, we'll teach you what to look for in a dividend stock, using six important factors that every dividend growth i…
00:11:54
SHARE
SAVE
The Nanalyze Verdict: Intel Stock

The Nanalyze Verdict: Intel Stock

Intel $INTC stock is up 300% in a single year. Growing demand for CPUs, an investment from NVIDIA $NVDA and the U.S. government, and a partnership with SpaceX $SPCX have sent Intel stock soaring, but is this hype or substance? In this video, we'll look at Intel's valuation and the truth behind the …
00:12:03
SHARE
SAVE
The Nanalyze Verdict: Cerebras Stock

The Nanalyze Verdict: Cerebras Stock

Cerebras stock has been incredibly popular lately among retail investors, but is there any substance to the hype? This company has a goal of taking down NVIDIA by developing plate-sized wafer-scale engines, or extremely high-powered, highly efficient semiconductors. With a steep valuation and a lot…
00:13:33
SHARE
SAVE
Disclaimer: The podcast and artwork embedded on this page are from Nanalyze, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
PROMOTED
Listen411.com: Lightning-fast Podcast Transcription and Summarization. Transcribe 1-hour audio in under 1 minute. Pay-as-you-go.
Listen411.com: Lightning-fast Podcast Transcription and Summarization. Transcribe 1-hour audio in under 1 minute. Pay-as-you-go.
Audio to Text

RECOMMENDATIONS
Use API to fetch this episode